Nesseler, J.P.; Lee, M.-H.; Nguyen, C.; Kalbasi, A.; Sayre, J.W.; Romero, T.; Nickers, P.; McBride, W.H.; Schaue, D.
Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy. Cancers 2020, 12, 714.
https://doi.org/10.3390/cancers12030714
AMA Style
Nesseler JP, Lee M-H, Nguyen C, Kalbasi A, Sayre JW, Romero T, Nickers P, McBride WH, Schaue D.
Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy. Cancers. 2020; 12(3):714.
https://doi.org/10.3390/cancers12030714
Chicago/Turabian Style
Nesseler, Jean Philippe, Mi-Heon Lee, Christine Nguyen, Anusha Kalbasi, James W. Sayre, Tahmineh Romero, Philippe Nickers, William H. McBride, and Dörthe Schaue.
2020. "Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy" Cancers 12, no. 3: 714.
https://doi.org/10.3390/cancers12030714
APA Style
Nesseler, J. P., Lee, M.-H., Nguyen, C., Kalbasi, A., Sayre, J. W., Romero, T., Nickers, P., McBride, W. H., & Schaue, D.
(2020). Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy. Cancers, 12(3), 714.
https://doi.org/10.3390/cancers12030714